Klavocin

Amoxicillin, the active ingredient in Klavocin, is a Penicillin beta-lactam antibiotic presented as an injection solution for intravenous use. It treats a range of bacterial infections in both adult and pediatric patients, often in hospital settings where rapid systemic exposure is required.

GNH USA supplies Klavocin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Klavocin is a broad‑spectrum antibacterial that targets bacterial infections across several organ systems.

- Respiratory tract infections: effective against the causative bacteria, helping to resolve pneumonia and bronchitis. - Skin and soft tissue infections: eradicates susceptible organisms, facilitating wound healing and reducing cellulitis. - Intra‑abdominal infections: provides coverage for mixed aerobic and anaerobic pathogens in peritonitis and postoperative infections. - Urinary tract infections: eliminates common uropathogens, aiding recovery from cystitis and pyelonephritis.

Adverse reactions may occur with any antibiotic therapy and should be monitored.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Rash: non‑specific skin eruption. - Injection site pain: localized discomfort during or after administration. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Clostridioides difficile‑associated diarrhea: severe colitis requiring medical attention. - Stevens‑Johnson syndrome: rare mucocutaneous disorder. - Hepatic necrosis: rare but serious liver injury.

Careful assessment and monitoring are required when using Klavocin. - Renal impairment: dose adjustment may be necessary based on creatinine clearance. - Hepatic dysfunction: monitor liver function tests during therapy. - Known penicillin allergy: avoid use to prevent hypersensitivity reactions. - Pregnancy Category B: prescribe only when clearly indicated. - Concomitant anticoagulants: monitor coagulation parameters for potential interaction. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Klavocin may interact with several medications; awareness of these interactions helps optimize safety.

Major Interactions (Avoid): - Probenecid: can increase amoxicillin plasma concentrations. - Allopurinol: heightened risk of rash. - Methotrexate: may enhance toxicity. - Oral contraceptives: possible reduction in efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: may potentiate anticoagulant effect, requiring INR monitoring. - Diuretics: can affect renal clearance of the drug. - Macrolide antibiotics: additive gastrointestinal side effects may occur.